Trial · NCT02536833
Results by group52
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 52
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee | 0.03 mg SM04690 | -23.3 | Standard Error 2.2 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee | 0.07 mg SM04690 | -23.5 | Standard Error 2.1 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee | 0.23 mg SM04690 | -21.3 | Standard Error 2.2 | score on a scale | |
| Change From Baseline Osteoarthritis (OA) Pain in the Target Knee | Placebo | -22.1 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee | 0.03 mg SM04690 | -24.7 | Standard Error 2.3 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee | 0.07 mg SM04690 | -27.3 | Standard Error 2.0 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee | 0.23 mg SM04690 | -23.3 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Pain in the Target Knee | Placebo | -24.4 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.03 mg SM04690 | -24.5 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.07 mg SM04690 | -26.3 | Standard Error 2.0 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.23 mg SM04690 | -22.6 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | Placebo | -22.8 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.03 mg SM04690 | -25.1 | Standard Error 2.2 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.07 mg SM04690 | -28.6 | Standard Error 2.0 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | 0.23 mg SM04690 | -24.1 | Standard Error 2.0 | score on a scale | |
| Change From Baseline OA Function in the Target Knee | Placebo | -25.1 | Standard Error 2.1 | score on a scale | |
| Change From Baseline OA Disease Activity as Assessed by the Patient | 0.03 mg SM04690 | -18.1 | Standard Error 2.3 | mm | |
| Change From Baseline OA Disease Activity as Assessed by the Patient | 0.07 mg SM04690 | -13.7 | Standard Error 2.3 | mm | |
| Change From Baseline OA Disease Activity as Assessed by the Patient | 0.23 mg SM04690 | -14.6 | Standard Error 2.6 | mm | |
| Change From Baseline OA Disease Activity as Assessed by the Patient | Placebo | -14.0 | Standard Error 2.3 | mm |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02536833/results